- Sort by Average rating
- Display 15 Products per page
Published: September 18, 2018 | Price: $3,500.00 – $7,990.00
IVD in Eastern Europe IVD companies continue to explore opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class. Eastern European markets are ripe for change. Many countries are engaging in healthcare reform programs to meet the growing demand for innovative products while containing costs in an increasingly...Published: August 27, 2018 | Price: $7,500.00 – $15,000.00
This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 11th edition of this comprehensive look at the IVD industry. At 1,800 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets. The report provides market size and forecasts to 2023 for defined segments of the IVD market...Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....Published: June 7, 2018 | Price: $99.00 – $198.00
A summary of major trends in the IVD industry, from harmonization to Cardiac marker testing.Published: June 5, 2018 | Price: $3,995.00 – $7,990.00
The prenatal and newborn genetic screening and diagnostic testing market has already become a significant market, and it continues to grow – driven by several major factors. The number of genetic tests continues to grow. While many discoveries have been made about the causes of genetic disorders, there remains much more to learn before many of these discoveries can be used as clinical tests – but progress is also being made on this front. While potential causes of inherited disorders...Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...Published: April 10, 2018 | Price: $4,500.00 – $9,000.00
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology) Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in...Published: March 30, 2018 | Price: $3,995.00 – $7,990.00
What is The Market for Outsourced Manufacturing of IVD Products? Valued at more than $12 billion in 2017, the global OEM in vitro diagnostic (IVD) manufacturing segment is well positioned for long-term growth. Several trends and factors will boost the revenue potential of this business. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to expand product lines, broaden manufacturing capacity and capabilities, and serve selected customers. Contract IVD...Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: March 27, 2018 | Price: $995.00 – $1,990.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018. Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures...Published: March 22, 2018 | Price: $2,995.00 – $5,995.00
This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players. As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...Published: March 21, 2018 | Price: $1,500.00 – $3,000.00
This report provides market estimates and forecasts for point-of-care glucose testing. Information in this report is from the latest published figures for companies participating in the market as well as recent interviews. The following markets analysis is provided in this report: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level) POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW) Global POC Glucose Self-Testing Market (includes continuous glucose devices) ...Published: February 26, 2018 | Price: $5,500.00 – $11,000.00
Infectious Disease Testing: World Market Analysis (HIV, Hepatitis, Blood Screening With over 400 tables to illustrate the analysis and provide solid business planning metrics, The World Market for Infectious Disease Diagnostic Diagnostics Testing, covers 30 areas of infectious diseases in 25 countries and regions. Diseases and technology categories segmented and forecasted in this report include: Blood Screening Immunoassay Blood Screening NAT Influenza Tests Strep A Test RSV Testing Malaria Tests Dengue Testing HIV Tests – Laboratories HIV Tests – POC...Published: February 16, 2018 | Price: $3,995.00 – $7,990.00
What is the Size of the Point of Care Diagnostic Testing Market? This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will...Published: January 25, 2018 | Price: $3,995.00 – $7,900.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...